Literature DB >> 7722410

A direct signaling pathway through tyrosine kinase activation of SH2 domain-containing transcription factors.

X Y Fu1.   

Abstract

Studies on the mechanism of interferon-induced gene expression revealed a direct signaling pathway from cell surface receptors to transcription factors. In this pathway, signal transduction is mediated by a new class of transcription factor STAT (signal transducer and activator of transcription). We have shown that STAT factors contain Src homology region 2 and 3 domains and are phosporylated and activated in the cytoplasm by receptor associated tyrosine kinases. The activated transcription factors then translocate to the nucleus, joined by a nuclear DNA binding factor, to form an active transcriptional complex. Recent studies have shown that this direct signaling pathway is the key to control of gene expression induced by many cytokines and growth factors.

Mesh:

Substances:

Year:  1995        PMID: 7722410     DOI: 10.1002/jlb.57.4.529

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

1.  Identification and functional characterization of a second chain of the interleukin-10 receptor complex.

Authors:  S V Kotenko; C D Krause; L S Izotova; B P Pollack; W Wu; S Pestka
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

2.  A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation.

Authors:  Theresa Li-Yun Chang; Arevik Mosoian; Richard Pine; Mary E Klotman; John P Moore
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signaling.

Authors:  Ming Yan; Jiann-Kae Luo; Kenneth J Ritchie; Ikuya Sakai; Kasuto Takeuchi; Ruibao Ren; Dong-Er Zhang
Journal:  Blood       Date:  2007-03-20       Impact factor: 22.113

4.  UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity.

Authors:  Oxana A Malakhova; Keun Il Kim; Jiann-Kae Luo; Weiguo Zou; K G Suresh Kumar; Serge Y Fuchs; Ke Shuai; Dong-Er Zhang
Journal:  EMBO J       Date:  2006-05-18       Impact factor: 11.598

Review 5.  The JAK/STAT signaling pathway: from bench to clinic.

Authors:  Xiaoyi Hu; Jing Li; Maorong Fu; Xia Zhao; Wei Wang
Journal:  Signal Transduct Target Ther       Date:  2021-11-26

6.  STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity.

Authors:  Thomas Welte; Samuel S M Zhang; Tian Wang; Zhiyuan Zhang; David G T Hesslein; Zhinan Yin; Arihiro Kano; Yoshiki Iwamoto; En Li; Joseph E Craft; Alfred L M Bothwell; Erol Fikrig; Pandelakis A Koni; Richard A Flavell; Xin-Yuan Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

Review 7.  A Narrative Review of STAT Proteins in Diabetic Retinopathy: From Mechanisms to Therapeutic Prospects.

Authors:  Libing Hong; Yongqi Lin; Min Fu; Xiongyi Yang; Tong Wu; Yuxi Zhang; Zhuohang Xie; Jieli Yu; Hejia Zhao; Guoguo Yi
Journal:  Ophthalmol Ther       Date:  2022-10-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.